Glaukos Corp. (GKOS)
179.53
+2.83
(+1.60%)
USD |
NYSE |
Sep 02, 16:00
179.33
-0.20
(-0.11%)
Pre-Market: 20:00
Glaukos Research and Development Expense (TTM) : 177.17M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 177.17M |
| March 31, 2026 | 162.41M |
| December 31, 2025 | 150.61M |
| September 30, 2025 | 143.49M |
| June 30, 2025 | 140.16M |
| March 31, 2025 | 138.05M |
| December 31, 2024 | 136.42M |
| September 30, 2024 | 136.96M |
| June 30, 2024 | 135.52M |
| March 31, 2024 | 134.32M |
| December 31, 2023 | 138.77M |
| September 30, 2023 | 137.52M |
| June 30, 2023 | 133.09M |
| March 31, 2023 | 131.56M |
| December 31, 2022 | 123.27M |
| September 30, 2022 | 114.14M |
| June 30, 2022 | 114.11M |
| March 31, 2022 | 111.66M |
| December 31, 2021 | 106.00M |
| September 30, 2021 | 100.56M |
| June 30, 2021 | 92.02M |
| March 31, 2021 | 81.74M |
| Date | Value |
|---|---|
| December 31, 2020 | 85.39M |
| September 30, 2020 | 84.18M |
| June 30, 2020 | 81.15M |
| March 31, 2020 | 79.25M |
| December 31, 2019 | 68.31M |
| September 30, 2019 | 61.23M |
| June 30, 2019 | 57.16M |
| March 31, 2019 | 52.70M |
| December 31, 2018 | 49.68M |
| September 30, 2018 | 47.24M |
| June 30, 2018 | 43.85M |
| March 31, 2018 | 40.87M |
| December 31, 2017 | 38.90M |
| September 30, 2017 | 35.78M |
| June 30, 2017 | 33.78M |
| March 31, 2017 | 31.10M |
| December 31, 2016 | 29.22M |
| September 30, 2016 | 28.12M |
| June 30, 2016 | 26.48M |
| March 31, 2016 | 26.87M |
| December 31, 2015 | 25.05M |
| September 30, 2015 | 23.14M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Abbott Laboratories | 3.128B |
| Alphatec Holdings, Inc. | 76.69M |
| Artivion, Inc. | 35.10M |
| ICU Medical, Inc. | 86.32M |